Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder

An Analysis of the MTA Database

Benedetto Vitiello, Guillermo Perez Algorta, L. Eugene Arnold, Andrea L. Howard, Annamarie Stehli, Brooke S G Molina

Research output: Contribution to journalArticle

Abstract

Objective To assess the prevalence of psychotic symptoms among youths (14–25 years of age) with a childhood diagnosis of attention-deficit/hyperactivity disorder (ADHD) combined type. Method Participants in the Multimodal Treatment Study of Children with ADHD (MTA) and a local normative comparison group (LNCG) were systematically assessed 6, 8, 10, 12, 14, and 16 years after the original enrollment at a mean age of 8.5 years. Trained research assistants administered a psychosis screener, and positive screens were referred to study clinicians to confirm or exclude psychosis. Possible associations between screening positive and alcohol or substance use were assessed. Results Data were available from 509 MTA participants (88% of original MTA sample; mean age 25.1 years) and 276 LNCG participants (96% of original sample; mean age 24.6 years) at year 16. Twenty-six MTA participants (5%; 95% CI 3–7) and 11 LNCG participants (4%; 95% CI 2–6) screened positive for at least 1 psychotic symptom (p = .60). Most psychotic symptoms were transient. The prevalence of clinician-confirmed psychotic symptoms was 1.1% (95% CI 0.2–2.1) in the MTA group and 0.7% (0–1.7) in the LNCG (p = .72). Greater cannabis use was reported by those who screened positive (p < .05) and were confirmed positive (p < .01). Conclusion There was no evidence that ADHD increased the risk for psychotic symptoms. In the ADHD and normative comparison groups, more frequent cannabis use was associated with a greater likelihood of experiencing psychotic symptoms, thus supporting the recommendation that youth should not use cannabis.

Original languageEnglish (US)
Pages (from-to)336-343
Number of pages8
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume56
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Pemetrexed
Attention Deficit Disorder with Hyperactivity
Databases
Cannabis
Psychotic Disorders
Combined Modality Therapy
Alcohols
Research

Keywords

  • attention-deficit/hyperactivity disorder
  • cannabis
  • psychosis
  • screening

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder : An Analysis of the MTA Database. / Vitiello, Benedetto; Perez Algorta, Guillermo; Arnold, L. Eugene; Howard, Andrea L.; Stehli, Annamarie; Molina, Brooke S G.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 56, No. 4, 01.04.2017, p. 336-343.

Research output: Contribution to journalArticle

Vitiello, Benedetto ; Perez Algorta, Guillermo ; Arnold, L. Eugene ; Howard, Andrea L. ; Stehli, Annamarie ; Molina, Brooke S G. / Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder : An Analysis of the MTA Database. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2017 ; Vol. 56, No. 4. pp. 336-343.
@article{6d1ec1b4a7504e37a7ee60fce414df22,
title = "Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database",
abstract = "Objective To assess the prevalence of psychotic symptoms among youths (14–25 years of age) with a childhood diagnosis of attention-deficit/hyperactivity disorder (ADHD) combined type. Method Participants in the Multimodal Treatment Study of Children with ADHD (MTA) and a local normative comparison group (LNCG) were systematically assessed 6, 8, 10, 12, 14, and 16 years after the original enrollment at a mean age of 8.5 years. Trained research assistants administered a psychosis screener, and positive screens were referred to study clinicians to confirm or exclude psychosis. Possible associations between screening positive and alcohol or substance use were assessed. Results Data were available from 509 MTA participants (88{\%} of original MTA sample; mean age 25.1 years) and 276 LNCG participants (96{\%} of original sample; mean age 24.6 years) at year 16. Twenty-six MTA participants (5{\%}; 95{\%} CI 3–7) and 11 LNCG participants (4{\%}; 95{\%} CI 2–6) screened positive for at least 1 psychotic symptom (p = .60). Most psychotic symptoms were transient. The prevalence of clinician-confirmed psychotic symptoms was 1.1{\%} (95{\%} CI 0.2–2.1) in the MTA group and 0.7{\%} (0–1.7) in the LNCG (p = .72). Greater cannabis use was reported by those who screened positive (p < .05) and were confirmed positive (p < .01). Conclusion There was no evidence that ADHD increased the risk for psychotic symptoms. In the ADHD and normative comparison groups, more frequent cannabis use was associated with a greater likelihood of experiencing psychotic symptoms, thus supporting the recommendation that youth should not use cannabis.",
keywords = "attention-deficit/hyperactivity disorder, cannabis, psychosis, screening",
author = "Benedetto Vitiello and {Perez Algorta}, Guillermo and Arnold, {L. Eugene} and Howard, {Andrea L.} and Annamarie Stehli and Molina, {Brooke S G}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.jaac.2017.01.016",
language = "English (US)",
volume = "56",
pages = "336--343",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder

T2 - An Analysis of the MTA Database

AU - Vitiello, Benedetto

AU - Perez Algorta, Guillermo

AU - Arnold, L. Eugene

AU - Howard, Andrea L.

AU - Stehli, Annamarie

AU - Molina, Brooke S G

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objective To assess the prevalence of psychotic symptoms among youths (14–25 years of age) with a childhood diagnosis of attention-deficit/hyperactivity disorder (ADHD) combined type. Method Participants in the Multimodal Treatment Study of Children with ADHD (MTA) and a local normative comparison group (LNCG) were systematically assessed 6, 8, 10, 12, 14, and 16 years after the original enrollment at a mean age of 8.5 years. Trained research assistants administered a psychosis screener, and positive screens were referred to study clinicians to confirm or exclude psychosis. Possible associations between screening positive and alcohol or substance use were assessed. Results Data were available from 509 MTA participants (88% of original MTA sample; mean age 25.1 years) and 276 LNCG participants (96% of original sample; mean age 24.6 years) at year 16. Twenty-six MTA participants (5%; 95% CI 3–7) and 11 LNCG participants (4%; 95% CI 2–6) screened positive for at least 1 psychotic symptom (p = .60). Most psychotic symptoms were transient. The prevalence of clinician-confirmed psychotic symptoms was 1.1% (95% CI 0.2–2.1) in the MTA group and 0.7% (0–1.7) in the LNCG (p = .72). Greater cannabis use was reported by those who screened positive (p < .05) and were confirmed positive (p < .01). Conclusion There was no evidence that ADHD increased the risk for psychotic symptoms. In the ADHD and normative comparison groups, more frequent cannabis use was associated with a greater likelihood of experiencing psychotic symptoms, thus supporting the recommendation that youth should not use cannabis.

AB - Objective To assess the prevalence of psychotic symptoms among youths (14–25 years of age) with a childhood diagnosis of attention-deficit/hyperactivity disorder (ADHD) combined type. Method Participants in the Multimodal Treatment Study of Children with ADHD (MTA) and a local normative comparison group (LNCG) were systematically assessed 6, 8, 10, 12, 14, and 16 years after the original enrollment at a mean age of 8.5 years. Trained research assistants administered a psychosis screener, and positive screens were referred to study clinicians to confirm or exclude psychosis. Possible associations between screening positive and alcohol or substance use were assessed. Results Data were available from 509 MTA participants (88% of original MTA sample; mean age 25.1 years) and 276 LNCG participants (96% of original sample; mean age 24.6 years) at year 16. Twenty-six MTA participants (5%; 95% CI 3–7) and 11 LNCG participants (4%; 95% CI 2–6) screened positive for at least 1 psychotic symptom (p = .60). Most psychotic symptoms were transient. The prevalence of clinician-confirmed psychotic symptoms was 1.1% (95% CI 0.2–2.1) in the MTA group and 0.7% (0–1.7) in the LNCG (p = .72). Greater cannabis use was reported by those who screened positive (p < .05) and were confirmed positive (p < .01). Conclusion There was no evidence that ADHD increased the risk for psychotic symptoms. In the ADHD and normative comparison groups, more frequent cannabis use was associated with a greater likelihood of experiencing psychotic symptoms, thus supporting the recommendation that youth should not use cannabis.

KW - attention-deficit/hyperactivity disorder

KW - cannabis

KW - psychosis

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=85014118186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014118186&partnerID=8YFLogxK

U2 - 10.1016/j.jaac.2017.01.016

DO - 10.1016/j.jaac.2017.01.016

M3 - Article

VL - 56

SP - 336

EP - 343

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 4

ER -